Literature DB >> 15369789

Poly(U) and polyadenylation termination signals are interchangeable for terminating the expression of shRNA from a pol II promoter.

Jun Song1, Shen Pang, Yingchun Lu, Robert Chiu.   

Abstract

Most short hairpin RNA (shRNA)-expressing vectors use RNA polymerase III promoters, as expression of shRNAs from RNA polymerase II promoters is not well understood, due to the lack of defined transcription initiation sites and functional localization of the transcription termination signal. Here we describe a modified cytomegavirus (CMV) promoter, an RNA polymerase II promoter, to express shRNAs with only four overhangs at the 5' end. The expression of shRNAs from the modified CMV promoter was terminated by the transcription termination, the polyadenylation, or the poly(U) termination signal. These results demonstrated that the poly(U) and polyadenylation termination signals are interchangeable for terminating the expression of shRNAs from the CMV promoter and result in similar efficacies in inhibiting endogenous target genes in mammalian cells. Copyright 2004 Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15369789     DOI: 10.1016/j.bbrc.2004.08.128

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

Review 1.  RNA interference for improving the outcome of islet transplantation.

Authors:  Feng Li; Ram I Mahato
Journal:  Adv Drug Deliv Rev       Date:  2010-12-13       Impact factor: 15.470

2.  Broadening prime editing toolkits using RNA-Pol-II-driven engineered pegRNA.

Authors:  Shisheng Huang; Zhenwu Zhang; Wanyu Tao; Yao Liu; Xiangyang Li; Xiaolong Wang; Javad Harati; Peng-Yuan Wang; Xingxu Huang; Chao-Po Lin
Journal:  Mol Ther       Date:  2022-07-06       Impact factor: 12.910

Review 3.  Immunological research using RNA interference technology.

Authors:  Chih-Ping Mao; Yen-Yu Lin; Chien-Fu Hung; T-C Wu
Journal:  Immunology       Date:  2007-04-12       Impact factor: 7.397

4.  Optimization and comparison of knockdown efficacy between polymerase II expressed shRNA and artificial miRNA targeting luciferase and Apolipoprotein B100.

Authors:  Piotr Maczuga; Annemart Koornneef; Florie Borel; Harald Petry; Sander van Deventer; Tita Ritsema; Pavlina Konstantinova
Journal:  BMC Biotechnol       Date:  2012-07-24       Impact factor: 2.563

5.  Hybrid cytomegalovirus-U6 promoter-based plasmid vectors improve efficiency of RNA interference in zebrafish.

Authors:  Jianguo Su; Zuoyan Zhu; Feng Xiong; Yaping Wang
Journal:  Mar Biotechnol (NY)       Date:  2008-03-06       Impact factor: 3.727

6.  Evaluating target silencing by short hairpin RNA mediated by the group I intron in cultured mammalian cells.

Authors:  Kousei Noguchi; Yoshio Ishitu; Hiroshi Takaku
Journal:  BMC Biotechnol       Date:  2011-07-25       Impact factor: 2.563

7.  Ribozyme Mediated gRNA Generation for In Vitro and In Vivo CRISPR/Cas9 Mutagenesis.

Authors:  Raymond Teck Ho Lee; Ashley Shu Mei Ng; Philip W Ingham
Journal:  PLoS One       Date:  2016-11-10       Impact factor: 3.240

8.  Regulation of U6 promoter activity by transcriptional interference in viral vector-based RNAi.

Authors:  Linghu Nie; Meghna Das Thakur; Yumei Wang; Qin Su; Yongliang Zhao; Yunfeng Feng
Journal:  Genomics Proteomics Bioinformatics       Date:  2010-09       Impact factor: 7.691

9.  A novel approach for inhibition of HIV-1 by RNA interference: counteracting viral escape with a second generation of siRNAs.

Authors:  Olivier ter Brake; Ben Berkhout
Journal:  J RNAi Gene Silencing       Date:  2005-10-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.